Bio
Dr. Tushar Desai specializes in the treatment of general pulmonary and Interstitial Lung Diseases like Idiopathic Pulmonary Fibrosis (IPF). He has practiced pulmonary medicine since 2002.
Dr. Desai has a special interest in understanding the development and progression of diseases like IPF, Chronic Obstructive Pulmonary Disease (COPD), and lung adenocarcinoma, as well as in understanding how native lung stem cells function to repair the lung gas exchange surface after injury.
Clinical Focus
- Pulmonary Disease
- Interstitial Lung Diseases
Academic Appointments
-
Associate Professor, Medicine - Pulmonary & Critical Care Medicine
-
Member, Bio-X
-
Member, Stanford Cancer Institute
Honors & Awards
-
Genome Editing to Correct Cystic Fibrosis Mutations in Airway Stem Cells, California Institute of Regenerative Medicine (CIRM) (2017-2019)
-
Woods Family Endowed Faculty Scholar, Stanford Child Health Research Institute (2016-2021)
-
In Situ Identification and Mapping of Alveolar Stem Cells at Single Cell Resolution in Human Lungs, NIH/NHLBI (2016-2017)
-
A Genetic Dissection of Lung Adenoma Initiation and Progression, American Lung Association, Lung Cancer Discovery Award (2015-2017)
-
Selective Aging of the Lungs: Using Conditional Klotho Deletion to Identify the Basis for Emphysema, Glenn Center for the Biology of Aging Seed Grant 2014 (2015-2017)
-
Single Cell Profiling and in vivo Cellular Interrogation of Alveolar Stem Cells, NIH/NHLBI (2015-2016)
-
In Situ Transcriptome Profiling in Histological Sections, Stanford Bio-X Interdisciplinary Initiatives Program 2014 (2014-2016)
-
Interrogation of Individual Cells to Identify Progenitor Cells and Their Niches (U01), NIH/NHLBI (2014-2016)
-
ITI Faculty Seed Grant 2014, Stanford Institute for Immunity, Transplantation, and Infection (2014-2015)
-
Development and Maintenance of the Alveolar Type 1 Cell (K08), NIH/NHLBI (2008-2013)
-
Fellowship in Pulmonary Research, Parker B. Francis Foundation (2006-2009)
-
Retinoic Acid in Early Lung Morphogenesis, GlaxoSmithKline Pulmonary Fellowship Award (2002-2003)
-
Robert Dawson Evans Fellow Excellence in Teaching Award, Boston University School of Medicine, Department of Internal Medicine (2000)
-
House Officer Research Award, University of Michigan Hospitals, Department of Internal Medicine (1998)
-
Worth F. Bloom M25 Prize, Tufts University School of Medicine (1995)
Boards, Advisory Committees, Professional Organizations
-
Member, Scientific Advisory Board, UK Regenerative Medicine Platform, Engineered Cell Environment Hub (2018 - Present)
-
Member, Scientific Advisory Committee, American Thoracic Society (ATS) (2015 - Present)
Professional Education
-
Fellowship:Boston University Pulmonary and Critical Care Fellowship (2002) MA
-
Residency:University of Michigan Health System Internal Medicine Residency (1998) MI
-
Internship:University of Michigan Health System Internal Medicine Residency (1996) MI
-
Medical Education:Tufts University School of Medicine Office of the Registrar (1995) MA
-
Board Certification: Pulmonary Disease, American Board of Internal Medicine (2001)
-
BA, Amherst College, Psychology (1991)
-
MD, MPH, Tufts University School of Medicine, Medicine, Public Health (1995)
Patents
-
Tushar Desai, Pehr Harbury, Daniel Riordan. "United States Patent 62/475,090 Molecular profiling using proximity ligation- in situ hybridization", Leland Stanford Junior University, Mar 22, 2017